Catalyst Wire Dossier Catalyst Wire Dossier

odanacatib

odanacatib · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for odanacatib, covering 2015-08-19 to 2018-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic Assessment of Single-Dose Odanacatib (MK-0822) in Subjects With Severe Renal Insufficiency (MK-0822-067) [Phase 1]

See pricing